High α -SMA expression in the tumor stroma is associated with adverse clinical parameters in mismatch repair–proficient colorectal cancers only
American Journal of Clinical Pathology · 08.03.2025 · 163 (3) · 464-472
DOI: 10.1093/ajcp/aqae145 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, online erschienen am 04.11.2024. Verfasst von Declan J Sculthorpe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Pathology Research, Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Actins, DNA Mismatch Repair, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bowel Research UK, Bowel Cancer UK.
Abstract (Originalsprache)
Objectives
As mismatch repair status confers differential prognosis in colorectal cancers, this study aimed to determine associations of α–smooth muscle actin (α-SMA) protein expression in mismatch repair–proficient (pMMR) and mismatch repair–deficient (dMMR) colorectal tumors with clinicopathologic and prognostic features.
Methods
Tissue microarrays from patients with colorectal cancer, immunostained with α-SMA, were assessed through digital image analysis. Total (n = 962), pMMR (n = 782), and dMMR (n = 156) stromal H-scores were assessed for associations with clinicopathologic and survival data.
Results
Higher α-SMA expression was correlated with pMMR status (P = 5.2223 × 10–8). In the pMMR subgroup, higher α-SMA stromal expression at the tumor periphery was correlated with higher T stage (P = .002), perineural invasion (P = .038), infiltrative tumor edge (P = .01), involved nodal status (P = .036), metastases (P = .013), synchronous metastases (P = .007), recurrence (P = .004), and both 3-year and 5-year survival (P = .018). dMMR tumors showed no significant correlations with α-SMA staining.
Conclusions
The findings highlight that immunostaining with α-SMA in pMMR colorectal tumors, especially at the tumor periphery, has the potential to identify patients with adverse prognostic features. Digital assessment of α-SMA may offer improved objectivity, accuracy, economy of time, and risk stratification for management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Pathology Research, Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK.
- Department of Histopathology, Nottingham University Hospitals NHS Trust, Queen's Medical Centre, Nottingham, UK.
ORCID-Profile: Declan J Sculthorpe, Amy Denton
Förderung
- Bowel Research UK
- Bowel Cancer UK
Zitieren
APA
Sculthorpe, D. J., Denton, A., Fadhil, W., Rusnita, D., Ilyas, M., & Mukherjee, A. (2025). High α -SMA expression in the tumor stroma is associated with adverse clinical parameters in mismatch repair–proficient colorectal cancers only. American Journal of Clinical Pathology, 163(3), 464-472. https://doi.org/10.1093/ajcp/aqae145
Vancouver
Sculthorpe DJ, Denton A, Fadhil W, Rusnita D, Ilyas M, Mukherjee A. High α -SMA expression in the tumor stroma is associated with adverse clinical parameters in mismatch repair–proficient colorectal cancers only. American Journal of Clinical Pathology. 2025;163(3):464-472. doi:10.1093/ajcp/aqae145
BibTeX
@article{Sculthorpe2025,
author = {Sculthorpe, Declan J and Denton, Amy and Fadhil, Wakkas and Rusnita, Dewi and Ilyas, Mohammad and Mukherjee, Abhik},
title = {High α -SMA expression in the tumor stroma is associated with adverse clinical parameters in mismatch repair–proficient colorectal cancers only},
journal = {American Journal of Clinical Pathology},
year = {2025},
volume = {163},
number = {3},
pages = {464--472},
doi = {10.1093/ajcp/aqae145}
}
EUVIMED